Patents by Inventor Judith Hempel

Judith Hempel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted histidines
    Patent number: 5565480
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: October 15, 1996
    Assignee: SmithKline Beecham Corporation
    Inventors: John G. Gleason, Judith Hempel, David T. Hill, James Samanen, Joseph Weinstock
  • Method of antagonizing angiotensin II receptors in mammals using substituted [1H-Imidazol-5-YL] alkenoic acids
    Patent number: 5530017
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: June 25, 1996
    Assignee: SmithKline Beecham Corp
    Inventors: Gerald R. Girard, Judith Hempel, David T. Hill, James Samanen, Joseph Weinstock
  • Substituted histidines having angiotension II receptor antagonist activity
    Patent number: 5444081
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: February 19, 1993
    Date of Patent: August 22, 1995
    Assignee: SmithKline Beecham Corp
    Inventors: John G. Gleason, Judith Hempel, David T. Hill, James Samanen, Joseph Weinstock
  • Substituted 5-(alkyl)carboxamide imidazoles
    Patent number: 5234917
    Abstract: Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Type: Grant
    Filed: November 30, 1990
    Date of Patent: August 10, 1993
    Inventors: Joseph A. Finkelstein, Judith Hempel, Richard M. Keenan, James Samanen, Joseph Weinstock